MNDR · Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions operates a vertically integrated telehealth platform that bridges digital and physical care delivery — combining real-time video consultations, AI-driven diagnostics (like AI Facescan), e-pharmacy (MaNaShop), B2B pharmaceutical wholesale (MaNaPharma), and enterprise health benefits (MaNaCare). Its business model targets structural inefficiencies in Southeast Asia’s healthcare system: aging populations, chronic disease burdens, and fragmented access — positioning itself as a '360-degree' ecosystem rather than a point solution. The company claims global reach across 18 jurisdictions, though its core operations remain anchored in Singapore, with subsidiaries in Vietnam, Malaysia, Indonesia, and the Philippines. Despite this geographic ambition, its financial trajectory shows contraction: revenue fell 45.3% year-over-year to $7.65 million in FY2025, with net loss widening to $3.38 million — a reversal from pandemic-fueled growth, underscoring vulnerability to demand shifts and regulatory headwinds. Critically, one of its subsidiaries, Manadr Clinic Pte. Ltd., lost its telemedicine license in December 2024 due to non-compliance, a material setback that directly undermines its core service offering and exposes reputational and operational fragility. This event, coupled with a $4.36 million net cash outflow from operations in FY2025 and just $1.03 million in cash, triggers a formal 'substantial doubt' disclosure regarding its ability to continue as a going concern — a red flag for investors assessing sustainability. The current offering is not a traditional IPO but a resale registration of 7.97 million Class A shares held by YA II PN, Ltd., a Cayman Islands fund, under a $10 million committed equity financing arrangement. While the company retains discretion over timing and volume of future issuances, the structure introduces dilution risk and price volatility: shares are priced at 97% of trailing VWAP, with no floor unless specified, and the selling shareholder may resell at any time. Governance is further complicated by a dual-class capital structure where founders and insiders retain outsized control — Siaw Tung Yeng, Teoh Pui Pui, and Siaw Tun Mine collectively hold 74.1% of voting power via Class B shares, yet only 37.4% of economic interest. This concentration, combined with Cayman Islands domicile and foreign private issuer status, limits investor protections relative to U.S.-domestic peers. Regulatory exposure spans multiple jurisdictions: Singapore’s HCSA compliance failures have already triggered enforcement action; Vietnam’s less-developed legal framework creates uncertainty around IP and bankruptcy; and Indonesia’s political volatility adds macro-level instability. With no dividends planned, high burn, and reliance on uncertain capital markets for survival, the investment thesis hinges entirely on execution of turnaround strategies — including AI monetization, international expansion, and strategic acquisitions — all while navigating intensifying scrutiny from health authorities and growing cybersecurity and data privacy liabilities.